Negative regulation of TCR signaling and T-cell activation by selective protein degradation

Current Opinion in Immunology

Volumn 15, Issue 3, 2003, Pages 315-320

  Jang, Ihn Kyung ^a,b   Gu, Hua ^a,b  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b New York Presbyterian Columbia University Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CBL PROTEIN; CD28 ANTIGEN; PROTEIN; PROTEIN TYROSINE KINASE; SRC LIKE ADAPTOR PROTEIN; SRC LIKE ADAPTOR PROTEIN 2; T LYMPHOCYTE RECEPTOR; UNCLASSIFIED DRUG;

NONHUMAN; PHYSIOLOGY; PROTEIN DEGRADATION; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION;

EID: 0038054541     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0952-7915(03)00048-7     Document Type: Review

References (38)

1. Joazeiro C.A., Wing S.S., Huang H., Leverson J.D., Hunter T., Liu Y.C. The tyrosine kinase negative regulator c-Cbl as a RING-type, E2- dependent ubiquitin-protein ligase. Science. 286:1999;309-312.
2. Weissman A.M. Themes and variations on ubiquitylation. Nat. Rev. Mol. Cell Biol. 2:2001;169-178.
3. Liu H., Rhodes M., Wiest D.L., Vignali D.A. On the dynamics of TCR:CD3 complex cell surface expression and downmodulation. Immunity. 13:2000;665-675.
4. Valitutti S., Muller S., Cella M., Padovan E., Lanzavecchia A. Serial triggering of many T-cell receptors by a few peptide-MHC complexes. Nature. 375:1995;148-151.
5. Bachmann M.F., Oxenius A., Speiser D.E., Mariathasan S., Hengartner H., Zinkernagel R.M., Ohashi P.S. Peptide-induced T cell receptor down-regulation on naive T cells predicts agonist/partial agonist properties and strictly correlates with T cell activation. Eur. J. Immunol. 27:1997;2195-2203.
6. Itoh Y., Hemmer B., Martin R., Germain R.N. Serial TCR engagement and down-modulation by peptide:MHC molecule ligands: relationship to the quality of individual TCR signaling events. J. Immunol. 162:1999;2073-2080.
7. Weiss A., Littman D.R. Signal transduction by lymphocyte antigen receptors. Cell. 76:1994;263-274.
8. Luton F., Buferne M., Davoust J., Schmitt-Verhulst A.M., Boyer C. Evidence for protein tyrosine kinase involvement in ligand-induced TCR/CD3 internalization and surface redistribution. J. Immunol. 153:1994;63-72.
9. Luton F., Buferne M., Legendre V., Chauvet E., Boyer C., Schmitt-Verhulst A.M. Role of CD3γ and CD3δ cytoplasmic domains in cytolytic T lymphocyte functions and TCR/CD3 down-modulation. J. Immunol. 158:1997;4162-4170.
10. Legendre V., Guimezanes A., Buferne M., Barad M., Schmitt-Verhulst A.M., Boyer C. Antigen-induced TCR-CD3 down-modulation does not require CD3δ or CD3γ cytoplasmic domains, necessary in response to anti-CD3 antibody. Int. Immunol. 11:1999;1731-1738.
11. Lanzavecchia A., Lezzi G., Viola A. From TCR engagement to T cell activation: a kinetic view of T cell behavior. Cell. 96:1999;1-4.
12. Lupher M.L., Rao N., Eck M.J., Band H. The Cbl protooncoprotien: a negative regulator of immune receptor signal transduction. Immunol. Today. 20:1999;375-382.
13. Thien C.B., Langdon W.Y. Cbl: many adaptations to regulate protein tyrosine kinases. Nat. Rev. Mol. Cell Biol. 2:2001;294-307.
14. Murphy M.A., Schnall R.G., Venter D.J., Barnett L., Bertoncello I., Thien C.B., Langdon W.Y., Bowtell D.D. Tissue hyperplasia and enhanced T-cell signalling via ZAP-70 in c-Cbl- deficient mice. Mol. Cell Biol. 18:1998;4872-4882.
15. Naramura M., Kole H.K., Hu R.J., Gu H. Altered thymic positive selection and intracellular signals in Cbl-deficient mice. Proc. Natl. Acad. Sci. U.S.A. 95:1998;15547-15552.
16. Panigada M., Porcellini S., Barbier E., Hoeflinger S., Cazenave P.A., Gu H., Band H., von Boehmer H., Grassi F. Constitutive endocytosis and degradation of the pre-T cell receptor. J. Exp. Med. 195:2002;1585-1597 Data presented in this paper clearly show that pre-TCR downmodulation in thymocytes, a puzzling phenomenon, is actively regulated by c-Cbl.
17. -/- dKO T cells are hyper-responsive to anti-TCR stimulation, and the dKO mice develop lethal systemic vasculitis. The hyperreponsiveness is probably linked to impaired TCR downmodulation, which prolongs the duration of TCR signaling. Confocal microscopy analysis and a receptor-labeling-chasing experiment show that the impaired TCR downmodulation is attributed to the block of ligand-stimulated TCR into the cells, as well as their trafficking to the lysosomes for degradation.
18. Babst M., Odorizzi G., Estepa E.J., Emr S.D. Mammalian tumor susceptibility gene 101 (TSG101) and the yeast homologue, Vps23p, both function in late endosomal trafficking. Traffic. 1:2000;248-258.
19. Hicke L. Protein regulation by monoubiquitin. Nat. Rev. Mol. Cell Biol. 2:2001;195-201.
20. Wang H.Y., Altman Y., Fang D., Elly C., Dai Y., Shao Y., Liu Y.C. Cbl promotes ubiquitination of the T cell receptor ζ through an adaptor function of Zap-70. J. Biol. Chem. 276:2001;26004-26011 These authors show clear evidence that c-Cbl mediates CD3ζ chain ubiquitination. They also show that this function depends on Zap-70, which acts as a linker between c-Cbl and CD3ζ. These data provide an explanation of how c-Cbl selectively promotes ubiquitination of the activated TCR complex.
21. Soubeyran P., Kowanetz K., Szymkiewicz I., Langdon W.Y., Dikic I. Cbl-CIN85-endophilin complex mediates ligand-induced downregulation of EGF receptors. Nature. 416:2002;183-187.
22. Petrlli A., Gilestro G.F., Lanzardo S., Comoglio P.M., Migone N., Giordano S. The endophilin-CIN85-Cbl complex mediates ligand-dependent downregulation of c-Met. Nature. 416:2002;187-190.
23. Sosinowski T., Pandey A., Dixit V.M., Weiss A. Src-like adaptor protein (SLAP) is a negative regulator of T cell receptor signaling. J. Exp. Med. 191:2000;463-474.
24. Holland S.J., Liao X.C., Mendenhall M.K., Zhou X., Pardo J., Chu P., Spencer C., Fu A., Sheng N., Yu P.et al. Functional cloning of Src-like adapter protein-2 (SLAP-2), a novel inhibitor of antigen receptor signaling. J. Exp. Med. 194:2001;1263-1276.
25. •].
26. •] shows furthermore that SLAP-2 promotes Zap-70 degradation and this regulation requires coordination by c-Cbl.
27. Lupher M.L. Jr., Rao N., Eck M.J., Band H. The Cbl protooncoprotein: a negative regulator of immune receptor signal transduction. Immunol. Today. 20:1999;375-382.
28. •].
29. •] suggest that c-Cbl regulates the Lck activation in T cells by eliminating it from the lipid rafts and promoting its ubiquitination and degradation.
30. Rao N., Lupher M.L. Jr., Ota S., Reedquist K.A., Druker B.J., Band H. The linker phosphorylation site Tyr292 mediates the negative regulatory effect of Cbl on ZAP-70 in T cells. J. Immunol. 164:2000;4616-4626.
31. Chiang Y.J., Kole H.K., Brown K., Naramura M., Fukuhara S., Hu R.J., Jang I.K., Gutkind J.S., Shevach E., Gu H. Cbl-b regulates the CD28 dependence of T-cell activation. Nature. 403:2000;216-220.
32. Bachmaier K., Krawczyk C., Kozieradzki I., Kong Y.Y., Sasaki T., Oliveira-dos-Santos A., Mariathasan S., Bouchard D., Wakeham A., Itie A.et al. Negative regulation of lymphocyte activation and autoimmunity by the molecular adaptor Cbl-b. Nature. 403:2000;211-216.
33. Zhang J., Bardos T., Li D., Gal I., Vermes C., Xu J., Mikecz K., Finnegan A., Lipkowitz S., Glant T.T. Cutting edge: regulation of T cell activation threshold by CD28 costimulation through targeting Cbl-b for ubiquitination. J. Immunol. 169:2002;2236-2240 This paper shows that co-stimulation by TCR and CD28 promotes ubiquitination and degradation of Cbl-b, thus providing an explanation for how CD28 co-stimulation enhances the T-cell response following TCR engagement.
34. Fang D., Liu Y.C. Proteolysis-independent regulation of PI3K by Cbl-b-mediated ubiquitination in T cells. Nat. Immunol. 2:2001;870-875 This paper describes that ubiquitination of p85, the regulatory subunit of PI-3 kinase, in T cells is mediated by Cbl-b. It also shows that ubiquitination of p85 prevents the recruitment of p85 to CD3 and CD28, leading to a low PI-3 kinase activity upon TCR engagement. In the absence of Cbl-b, p85 ubiquitination is reduced, resulting in an increased association of p85 with CD3 and CD28, as well as an enhanced PI-3 kinase activity. As PI-3 kinase functions upstream of Vav activation in T cells, these data thus provide an explanation how Vav activation is regulated by Cbl-b.
35. Yokoi N., Komeda K., Wang H.Y., Yano H., Kitada K., Saitoh Y., Seino Y., Yasuda K., Serikawa T., Seino S. Cblb is a major susceptibility gene for rat type 1 diabetes mellitus. Nat. Genet. 31:2002;391-394 This paper reports the first case in which Cbl-b is found to be a major factor responsible for the susceptibility of the type one diabetes in an existing autoimmune animal model.
36. Thien C.B., Langdon W.Y. Cbl: many adaptations to regulate protein tyrosine kinases. Nat. Rev. Mol. Cell Biol. 2:2001;294-307.
37. Fang D., Elly C., Gao B., Fang N., Altman Y., Joazeiro C., Hunter T., Copeland N., Jenkins N., Liu Y.C. Dysregulation of T lymphocyte function in itchy mice: a role for Itch in TH2 differentiation. Nat. Immunol. 3:2002;281-287 This paper describes a mutant mouse strain in which mutation in the Itch gene, an E3 ubiquitin ligase, leads to severe inflammatory disorder and constant itching of the skin. It is found that Itch mutant mice produce a high level of IgE in vivo, and Itch mutant T cells exhibit a biased differentiation potential toward Th2 cells in vitro. Transcription factor JunB is associated with the Itch protein, suggesting that Itch might regulate Th2 differentiation by controlling JunB ubiquitination.
38. Li B., Tournier C., Davis R.J., Flavell R.A. Regulation of IL-4 expression by the transcription factor JunB during T helper cell differentiation. EMBO J. 18:1999;420-432.